Genomtec S.A. received from the German company Dennemeyer Consulting GmbH a valuation of the Company’s intellectual property portfolio. Accord-ing to the DIN/ISO 77100 standard adopted by Dennemeyer, covering 9 patents held by Genomtec and 26 patent applications, as well as the conversion of all patent applications into patents, as well as a 14-year protection period for the entire IP (intellectual property) portfolio, the fair value of Genomtec’s intellectual property was estimated at EUR 191.336 million.